modelClopidogrel
Extends from Clopidogrel_Jung2024_reference.
Information
The default model of clopidogrel: Clopidogrel_Jung2024_reference, chosen among the models extracted from papers (reviewer verdict, ground-truth agreement, completeness). All models of clopidogrel in this package:
Clopidogrel_Jung2024_referenceClopidogrel_Jung2024_PD_pruClopidogrel_Lee2012_PD_relative_platelet_aggregationClopidogrel_Jung2024_reference_PGx_CYP2C19
About clopidogrel
Clopidogrel is an antiplatelet medicine used to lower the risk of heart attack, stroke, and other clot-related cardiovascular problems in people at high risk. It is widely used and remains authorised in the European Union, where several approved products are marketed for conditions such as acute coronary syndrome, myocardial infarction, and stroke.
Summary written by glm-5.3-flash from Wikidata Q410237 and the WHO ATC classification and the EMA medicines list; not checked by a person.
Identity, molar mass and metabolites: Clopidogrel.
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| Real | massRatio_m1 (from PK_3M_3C) | if MW > 0 and MW_m1 > 0 then MW_m1/MW else 1 | |
| Real | massRatio_m2 (from PK_3M_3C) | if MW > 0 and MW_m2 > 0 then MW_m2/MW else 1 | |
| Pharmacolibrary.Types.Mass | adminMass (from PK_3M_3C) | 1e-4 | oral dose mass, into the hepatic compartment (0 = no oral dose; an IV-only model sets 0) |
| Pharmacolibrary.Types.Mass | infusionMass (from PK_3M_3C) | 0 | IV / parenteral dose mass into the hepatic compartment (0 = no IV dose); bioavailability 1 |
| Integer | adminCount (from PK_3M_3C) | 1 | number of doses (-1 = unlimited) |
| Modelica.Units.SI.Time | adminPeriod (from PK_3M_3C) | 8*3600 | period of administration |
| Modelica.Units.SI.Time | adminDuration (from PK_3M_3C) | 1 | oral administration duration (a 1 s bolus into the gut, as in PeriodicDose_Enteral) |
| Modelica.Units.SI.Time | infusionDuration (from PK_3M_3C) | adminDuration | IV infusion duration (default: adminDuration, i.e. a bolus) |
| Modelica.Units.SI.Time | adminTime (from PK_3M_3C) | 60 | first administration time (s); 60 as in PK_1C, not 0 — a co-simulation FMU starting a dose pulse at t = 0 doses one communication step too long |
| Modelica.Units.SI.MassFraction | F (from PK_3M_3C) | 1 | bioavailability (0-1) |
| Pharmacolibrary.Types.TransferRate | ka (from PK_3M_3C) | 0.016666666666666666 | first order absorption rate |
| Modelica.Units.SI.Time | Tlag (from PK_3M_3C) | 600 | delay between oral administration and absorption |
| Types.Volume | Vd1 (from PK_3M_3C) | 0 | parent: hepatic (absorption) compartment volume |
| Types.Volume | Vd2 (from PK_3M_3C) | 0 | parent: central volume |
| Types.Volume | Vd3 (from PK_3M_3C) | 0 | parent: peripheral volume |
| Types.Volume | Vd1m1 (from PK_3M_3C) | 0 | metabolite 1: central volume |
| Types.Volume | Vd2m1 (from PK_3M_3C) | 0 | metabolite 1: peripheral volume (0 with qm11_m12 = qm12_m11 = 0 for a 1-compartment metabolite) |
| Types.Volume | Vd1m2 (from PK_3M_3C) | 0 | metabolite 2: central volume |
| Types.Volume | Vd2m2 (from PK_3M_3C) | 0 | metabolite 2: peripheral volume (0 with qm21_m22 = qm22_m21 = 0 for a 1-compartment metabolite) |
| Types.Clearance | q12 (from PK_3M_3C) | 0 | parent: hepatic -> central |
| Types.Clearance | q21 (from PK_3M_3C) | 0 | parent: central -> hepatic |
| Types.Clearance | q23 (from PK_3M_3C) | 0 | parent: central -> peripheral |
| Types.Clearance | q32 (from PK_3M_3C) | 0 | parent: peripheral -> central |
| Types.Clearance | q1_m11 (from PK_3M_3C) | 0 | formation of metabolite 1: hepatic -> M1 central (0 = no metabolite 1) |
| Types.Clearance | qm11_1 (from PK_3M_3C) | 0 | back-conversion: M1 central -> hepatic (usually 0) |
| Types.Clearance | qm11_m12 (from PK_3M_3C) | 0 | metabolite 1: central -> peripheral (0 = 1-compartment metabolite) |
| Types.Clearance | qm12_m11 (from PK_3M_3C) | 0 | metabolite 1: peripheral -> central |
| Types.Clearance | q1_m21 (from PK_3M_3C) | 0 | formation of metabolite 2: hepatic -> M2 central (0 = no metabolite 2) |
| Types.Clearance | qm21_1 (from PK_3M_3C) | 0 | back-conversion: M2 central -> hepatic (usually 0) |
| Types.Clearance | qm21_m22 (from PK_3M_3C) | 0 | metabolite 2: central -> peripheral (0 = 1-compartment metabolite) |
| Types.Clearance | qm22_m21 (from PK_3M_3C) | 0 | metabolite 2: peripheral -> central |
| Types.Clearance | CL1 (from PK_3M_3C) | 0 | parent: elimination from hepatic compartment by routes other than M1/M2 formation |
| Types.Clearance | CLm1 (from PK_3M_3C) | 0 | metabolite 1: elimination from central |
| Types.Clearance | CLm2 (from PK_3M_3C) | 0 | metabolite 2: elimination from central |
| Info › Molar masses | |||
| Modelica.Units.SI.MolarMass | MW (from PK_3M_3C) | 0 | parent molar mass [kg/mol]; 0 = not supplied |
| Modelica.Units.SI.MolarMass | MW_m1 (from PK_3M_3C) | 0 | metabolite 1 molar mass [kg/mol]; 0 = not supplied |
| Modelica.Units.SI.MolarMass | MW_m2 (from PK_3M_3C) | 0 | metabolite 2 molar mass [kg/mol]; 0 = not supplied |
Connectors
| Type | Name | Default | Description |
|---|---|---|---|
| Interfaces.ConcentrationPort_b | centralM1CPort (from PK_3M_3C) | metabolite 1 central compartment (e.g. to drive a PD model) | |
| Types.ConcentrationOutput | C_central (from PK_3M_3C) | parent concentration, central compartment | |
| Types.ConcentrationOutput | C_M1 (from PK_3M_3C) | metabolite 1 concentration, central compartment | |
| Types.ConcentrationOutput | C_M2 (from PK_3M_3C) | metabolite 2 concentration, central compartment |
Components
Revisions
- 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from default: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: default